Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Consulting and Clinical Psychology|April 17, 2001
Young adults' immediate and delayed reactions to simulated marital conflicts: implications for intergenerational patterns of violence in intimate relationshipsS Duggan, M O'Brien, J K Kennedy
International Endodontic Journal|January 1, 1994
A laboratory study of root fillings in teeth obturated by lateral condensation of gutta-percha or Thermafil obturatorsP M Dummer, L Lyle, J Rawle, et al.
Archives of Internal Medicine|August 1, 1980
Infectious complications of endoscopic retrograde cholangiopancreatography. A prospective assessmentD E Low, A B Micflikier, J K Kennedy, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|May 4, 2012
The rapid emergence of high level gentamicin resistance in enterococciK R Forward, J K Kennedy, P A Degagne, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microfloraD A Haase, G K Harding, M J Thomson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1987
Risk of bacteremia with endoscopic sphincterotomyD E Low, J P Shoenut, J K Kennedy, et al.
Archives of Internal Medicine|March 1, 1986
Infectious complications of endoscopic injection sclerotherapyD E Low, J P Shoenut, J K Kennedy, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|May 4, 2012
Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infectionsL K Selin, G K Harding, M J Thomson, et al.
Digestive Diseases and Sciences|November 1, 1987
Prospective assessment of risk of bacteremia with colonoscopy and polypectomyD E Low, J P Shoenut, J K Kennedy, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1988
Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infectionG J Sheehan, G K Harding, D A Haase, et al.
Pageof 2